The role of lymph node dissection in the management of urothelial carcinoma of the upper urinary tract

International Journal of Clinical Oncology

Volumn 16, Issue 3, 2011, Pages 170-178

  Kondo, Tsunenori ^a   Tanabe, Kazunari ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Kidney pelvis; Lymph node excision; Lymphatic metastasis; Transitional cell carcinoma; Ureteral neoplasms

Indexed keywords

ADVANCED CANCER; BLADDER CANCER; CANCER GRADING; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CYSTECTOMY; DISEASE ASSOCIATION; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; OPERATION DURATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; TRANSITIONAL CELL CARCINOMA;

EID: 85027955399     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-011-0234-2     Document Type: Review

References (44)

1. Cummings KB (1980) Nephroureterectomy: rationale in the management of transitional cell carcinoma of the upper urinary tract. Urol Clin North Am 7:569-578. (Pubitemid 11225744)
2. Oosterlinck W, Solsona E, van der Meijden AP et al (2004) EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. Eur Urol 46:147-154. (Pubitemid 38902728)
3. Brown GA, Busby JE, Wood CG et al (2006) Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: time to change the treatment paradigm? BJU Int 98:1176-1180. (Pubitemid 44721220)
4. Lughezzani G, Jeldres C, Isbarn H et al (2010) Temporal stage and grade migration in surgically treated patients with upper tract urothelial carcinoma. BJU Int 105:799-804.
5. Cauberg EC, Salomons MA, Kummerlin IP et al (2010) Trends in epidemiology and treatment of upper urinary tract tumours in the Netherlands 1995-2005: an analysis of PALGA, the Dutch national histopathology registry. BJU Int 105:922-927.
6. Lughezzani G, Sun M, Perrotte P et al (2009) Should bladder cuff excision remain the standard of care at nephroureterectomy in patients with urothelial carcinoma of the renal pelvis? A population- based study. Eur Urol 57:956-962.
7. Abouassaly R, Alibhai SM, Shah N et al (2010) Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma. Urology 76:895-901.
8. Grossman HB, Natale RB, Tangen CM et al (2003) Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349:859-866. (Pubitemid 37025405)
9. Stein JP, Lieskovsky G, Cote R et al (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1, 054 patients. J Clin Oncol 19:666-675. (Pubitemid 32120143)
10. Leissner J, Ghoneim MA, Abol-Enein H et al (2004) Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol 171:139-144. (Pubitemid 37549109)
11. Skinner DG (1982) Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference. J Urol 128:34-36. (Pubitemid 12048751)
12. Herr H, Lee C, Chang S et al (2004) Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report. J Urol 171:1823-1828.
13. Poulsen AL, Horn T, Steven K (1998) Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol 160:2015-2019.
14. Konety BR, Joslyn SA, O'Donnell MA (2003) Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base. J Urol 169:946-950. (Pubitemid 36188131)
15. Stein JP (2006) Lymphadenectomy in bladder cancer: how high is "high enough"? Urol Oncol 24:349-355. (Pubitemid 43963403)
16. Zehnder P, Desai M (2011) Extended lymph node dissection: bladder, kidney. Curr Opin Urol 21:110-114.
17. Batata MA, Whitmore WF, Hilaris BS et al (1975) Primary carcinoma of the ureter: a prognostic study. Cancer 35: 1626-1632.
18. Grabstald H, Whitmore WF, Melamed MR (1971) Renal pelvic tumors. Jama 218:845-854.
19. Ozsahin M, Zouhair A, Villa S et al (1999) Prognostic factors in urothelial renal pelvis and ureter tumours: a multicentre Rare Cancer Network study. Eur J Cancer 35:738-743. (Pubitemid 29258143)
20. McCarron JP Jr, Chasko SB, Gray GF Jr (1982) Systematic mapping of nephroureterectomy specimens removed for urothelial cancer: pathological findings and clinical correlations. J Urol 128:243-246. (Pubitemid 12027165)
21. Akaza H, Koiso K, Niijima T (1987) Clinical evaluation of urothelial tumors of the renal pelvis and ureter based on a new classification system. Cancer 59:1369-1375. (Pubitemid 17035487)
22. Sobin LH, Gospodarowicz MK, Wittekind Ch (2009) Renal pelvis and ureter (ICD-O C65, C66). TNM classification of malignant tumors, 7th edn. Wiley-Liss, New York, pp 258-261.
23. Sagalowsky AI, Jarrett TW (2007) Management of urothelial tumors of the renal pelvis and ureter. In: Wein AJ, Kavoussi LR, Novick AC et al (eds) Campbell-Walsh urology, 9th edn. Saunders, New York, pp 1653-1685.
24. Komatsu H, Tanabe N, Kubodera S et al (1997) The role of lymphadenectomy in the treatment of transitional cell carcinoma of the upper urinary tract. J Urol 157:1622-1624. (Pubitemid 27171738)
25. Miyake H, Hara I, Gohji K et al (1998) The significance of lymphadenectomy in transitional cell carcinoma of the upper urinary tract. Br J Urol 82:494-498. (Pubitemid 28477288)
26. Transitional Cell Cancer of the Renal Pelvis and Ureter Treatment (PDQ®) (database on the Internet) (2011). National Cancer Institute. Available from: http://www.cancer.gov/cancertopics/pdq/treatment/ transitionalcell/HealthProfessional.
27. Herr HW, Donat SM (2001) Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy. J Urol 165:62-64 (discussion 64).
28. Kondo T, Nakazawa H, Ito F et al (2007) Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract. Urology 69:265-269. (Pubitemid 46274933)
29. Assouad J, Riquet M, Foucault C et al (2006) Renal lymphatic drainage and thoracic duct connections: implications for cancer spread. Lymphology 39:26-32.
30. Kondo T, Nakazawa H, Ito F et al (2007) Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract. J Urol 178: 1212-1217 (discussion 1217). (Pubitemid 47368417)
31. Roscigno M, Cozzarini C, Bertini R et al (2008) Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract. Eur Urol 53:794-802.
32. Brausi MA, Gavioli M, De Luca G et al (2007) Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival. Eur Urol 52:1414-1420. (Pubitemid 47445989)
33. Abe T, Shinohara N, Muranaka M et al (2010) Role of lymph node dissection in the treatment of urothelial carcinoma of the upper urinary tract: multi-institutional relapse analysis and immunohistochemical re-evaluation of negative lymph nodes. Eur J Surg Oncol 36:1085-1091.
34. Roscigno M, Shariat SF, Margulis V et al (2009) Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol 181:2482-2489.
35. Lughezzani G, Jeldres C, Isbarn H et al (2010) A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma. Urology 75:118-124.
36. Herr HW (2003) Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy. Urology 61:105-108. (Pubitemid 36151723)
37. Koppie TM, Vickers AJ, Vora K et al (2006) Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed? Cancer 107:2368-2374. (Pubitemid 44748519)
38. Stein JP, SkinnerDG(2005) The role of lymphadenectomy in highgrade invasive bladder cancer. Urol Clin North Am 32:187-197. (Pubitemid 40603293)
39. Roscigno M, Shariat SF, Margulis V et al (2009) The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed? Eur Urol 56:512-518.
40. Kondo T, Hashimoto Y, Kobayashi H et al (2010) Templatebased lymphadenectomy in urothelial carcinoma of the upper urinary tract: impact on patient survival. Int J Urol 17:848-854.
41. Scolieri MJ, Paik ML, Brown SL et al (2000) Limitations of computed tomography in the preoperative staging of upper tract urothelial carcinoma. Urology 56:930-934.
42. Brown GA, Matin SF, Busby JE et al (2007) Ability of clinical grade to predict final pathologic stage in upper urinary tract transitional cell carcinoma: implications for therapy. Urology 70:252-256. (Pubitemid 47362246)
43. Brien JC, Shariat SF, Herman MP et al (2010) Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytologycan improve prediction of advanced upper tract urothelial carcinoma.J Urol 184:69-73.
44. Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205-213. (Pubitemid 38963009)